Truvestments Capital’s Alkermes ALKS Stock Holding History

Truvestments Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-131	Closed	-$3.42K	–	682
2022 Q4	$3.42K	Buy	+131	New	+$3.13K	﹤0.01%	613

Other funds holding ALKS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CWM

CIBC World Markets New York $20.8B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Truvestments Capital's ALKS Position: Q1 2023 in Review

Truvestments Capital sold out of Alkermes (ALKS) in Q1 2023, closing a stake of 131 shares — an estimated $3.42K sold.

Truvestments Capital first reported a position in ALKS in Q4 2022 and held it in 1 quarter. The position peaked at $3.42K in Q4 2022. 267 funds tracked by Wall St. Rank hold ALKS as of Q1 2023.

Truvestments Capital reported no remaining Alkermes position as of Q1 2023 after selling out during the quarter.
Truvestments Capital sold 131 Alkermes shares in Q1 2023, an estimated $3.42K.
Truvestments Capital first reported a position in Alkermes in Q4 2022 and held it in 1 quarter.
Truvestments Capital's Alkermes position peaked at $3.42K in Q4 2022.
267 funds tracked by Wall St. Rank held Alkermes as of Q1 2023.

Based on Truvestments Capital's 13F filing for Q1 2023, filed 12 May 2023.